Cyclooxygenase-2 inhibition

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/655 (2006.01)

Patent

CA 2313049

Selective inhibitors of cyclooxygenase-2 are used to treat liver disease and in combination with anti-viral drugs to treat virus-caused liver disorders. Selective inhibitors of cyclooxygenase-2 which also inhibit the synthesis of cyclooxygenase-2 improve over the efficacy of conventional selective inhibitors of cyclooxygenase-2 in the treatment of inflammatory conditions, Alzheimer's disease and cancer.

On utilise des inhibiteurs sélectifs de cyclooxygénase-2 pour traiter des hépatopathies et en combinaison avec des médicaments antiviraux afin de traiter des troubles hépatiques d'origine virale. Les inhibiteurs sélectifs de cyclooxygénase-2 inhibant également la synthèse de la cyclooxygénase-2, améliorent l'efficacité d'inhibiteurs sélectifs classiques de cyclooxygénase-2 dans le traitement d'états inflammatoires, de la maladie d'Alzheimer et du cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cyclooxygenase-2 inhibition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclooxygenase-2 inhibition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclooxygenase-2 inhibition will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1517942

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.